The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•13 April 2026•

1 min read

CRISPR Gene Editing Market Set for Robust Growth Through 2033, Report Finds

Fortified uniQure building, fences, caution tape, security cameras. FDA buildings, US flags, justice symbols. Charts on tablets and papers.

Key Facts

1Coherent Market Insights released a report forecasting strong growth for the CRISPR gene editing market through 2033.

2Key market players highlighted include CRISPR Therapeutics, Intellia Therapeutics, and Editas Medicine.

A new report from Coherent Market Insights forecasts a significant expansion in the biomedical CRISPR gene editing sector over the next decade. The study highlights strategic growth opportunities driven by rapid advancements in gene-editing technology and expanding biomedical applications. Key industry players identified in the report include CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), and Editas Medicine (EDIT). While market research reports often have a moderate immediate impact compared to clinical data, the long-term outlook for the biotechnology sector remains positive. Investors are increasingly focusing on these companies as the technology matures toward commercialization. The report underscores the potential for CRISPR to revolutionize healthcare through 2033.

Version History

1 additional source confirmed this story